Removal of acute lymphoblastic leukemia (ALL) cells from human bone marrow using monoclonal antibodies (MoAbs) and complement - A review
β Scribed by HERVE, P; RACADOT, E
- Book ID
- 123477214
- Publisher
- Elsevier Science
- Year
- 1985
- Weight
- 412 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0338-4535
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Autologous remission bone marrow is a potential source of repopulative stem cells after ablative chemoradiotherapy of tumor patients. Even with remission bone marrow, one major obstacle to use of autologous bone-marrow support is the danger of reinfusing viable tumor cells. This report describes a p
Autologous bone marrow transplantation (ABMT) may aid in the management of breast cancer, but is currently limited to patients without bone marrow metastases. In earlier studies, 5 logs of malignant clonogenic breast cancer cells could be eliminated from human bone marrow using a combination of chem